• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Median number of hours to resolve Severity One outages which occurred within the month (1)

Dictionary: The Office of Information Management provides and manages information technology (IT) and other related services to ensure FDA can carry out its mission of promoting and protecting public health in an efficient, effective, productive, and timely manner. One of the ways OIM ensures that FDA employees are able to sustain a high level of productivity is to resolve IT related issues as quickly as possible. Severity One outages are defined as a global failure where work is halted or a potential halt of work for multiple customers on a floor, building or entire Center. OIM tracks the number of Severity One outages that are received during the month and the median number of hours it took for OIM to resolve the issue. OIM strives to reduce the number of hours it takes to resolve Severity One outages and return services to our customers.

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetMedian
Oct 200932.0
Nov 200931.3
Dec 200931.0
Jan 201031.5
Feb 20103.8
Mar 201031.8
Apr 201031.4
May 201031.5
Jun 20103.9
Jul 201033.4
Aug 201032.2
Sep 201034.9

Footnotes

  • (1) An outage is resolved when the applicable service ticket is closed.

Number of Severity One outages reported in the month

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetNumber
Oct 2009N/A83
Nov 2009N/A74
Dec 2009N/A95
Jan 2010N/A49
Feb 2010N/A61
Mar 2010N/A70
Apr 2010N/A87
May 2010N/A61
Jun 2010N/A70
Jul 2010N/A99
Aug 2010N/A102
Sep 2010N/A121

FY 2010 Total: 972

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.